Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-23

FDA Approved: IPRATROPIUM BROMIDE INHALATION — Original Application (Armstrong Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Armstrong Pharmaceuticals' ipratropium bromide inhalation under an original ANDA. It is approved for relief of bronchospasm associated with chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE INHALATION (ipratropium bromide inhalation)

Snippet

ORIG AP for IPRATROPIUM BROMIDE INHALATION (IPRATROPIUM BROMIDE INHALATION)